Chinese Registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis

According to our analyses, duration of RA is the most important clinical factor related to the presence of comorbidities. In clinical practice, bDMARDs are given to patients with moderate to high disease activity, severe joint damage, and poor responses to conventional medications. [...]the association between bDMARDs and fractures in our results may only represent an impact of disease severity on the risk of fractures. [...]the information on comorbidities and medications in CREDIT was collected by interviewing patients and mainly based on their self-reports. [...]since all data in this cross... Mehr ...